Tezruly™ (terazosin) – New formulation approval
July 29, 2024 - The FDA approved Novitium’s Tezruly (terazosin) oral solution, for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH), and for the treatment of hypertension alone or with other antihypertensive agents, to lower blood pressure.